Table 3.
Infections.
| Patients Who Received PPSAs (n = 58) | Patients Who Did Not Receive PPSAs (n = 55) | P Value | |
|---|---|---|---|
| Surgical site infections | 0 (0%) | 2 (4%) | .24a |
| Deep infections, n (%) | 0 (0%) | 1 (2%) | .49a |
| Superficial infections, n (%) | 0 (0%) | 1 (2%) | .49a |
| Growth of a resistant organism | 1 (2%) | 2 (4%) | .61a |
| Growth of a blood culture, n (%) | 1 (2%) | 1 (2%) | 1a |
| Growth of a resistant organism in blood, n (%) | 1 (2%) | 0 (0%) | 1a |
| Growth of a urine culture, n (%) | 4 (7%) | 5 (9%) | .74a |
| Growth of a resistant organism in urine, n (%) | 0 (0%) | 2 (4%) | .24a |
| Growth of a CSF culture, n (%) | 0 (0%) | 0 (0%) | -- |
| Growth of a sputum culture, n (%) | 0 (0%) | 0 (0%) | -- |
| Clostridium difficile | 0 (0%) | 0 (0%) | -- |
Abbreviations: CSF, cerebrospinal fluid; PPSAs, prolonged prophylactic systemic antibiotics.
aFisher exact test.